Volume 10, Number 9—September 2004
Research
Viral Loads in Clinical Specimens and SARS Manifestations
I.F.N. Hung*, V.C.C. Cheng*, A.K.L. Wu†, B.S.F. Tang*, K.H. Chan*, C.M. Chu‡, M.M.L. Wong§, W.T. Hui*, L.L.M. Poon*, D.M.W. Tse§, K.S. Chan‡, P.C.Y. Woo*, S.K.P. Lau*, J.S.M. Peiris*, and K.Y. Yuen*
Table 4
Correlation of RT-qPCR clinical specimens taken during days 10 to 15 and laboratory values in 154 patients with SARSa
| Specimen | Lymphopenia |
Hepatic dysfunction |
Abnormal urinalysis results |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Y | N | p value; OR (CI) | Y | N | p value; OR (CI) | Y | N | p value; OR (CI) | |
| NPA (n = 142) | |||||||||
| RT-qPCR (+) (n = 60) | 56 | 4 | 0.8 | 40 | 20 | < 0.01; 2.5 (1.2-5.2) | 43 | 17 | 0.07 |
| RT-qPCR (–) (n = 82) | 70 | 12 | 38 | 44 | 52 | 30 | |||
| Median viral load (log10 copies/mL) | 0 | 0 | 0.3 | 2.7 | 0 | < 0.01 | 0 | 0 | 0.1 |
| Serum (n = 53) | |||||||||
| RT-qPCR (+) (n = 22) | 20 | 2 | 0.7 | 12 | 10 | 1 | 18 | 4 | 1 |
| RT-qPCR (–) (n = 31) | 26 | 5 | 19 | 12 | 26 | 5 | |||
| Median viral load (log10 copies/mL) | 0 | 0 | 0.4 | 0 | 0 | 0.9 | 0 | 0 | 0.5 |
| Stool (n = 94) | |||||||||
| RT-qPCR (+) (n = 82) | 75 | 7 | 0.2 | 46 | 36 | 0.1 | 62 | 20 | 0.2 |
| RT-qPCR (–) (n = 12) | 9 | 3 | 4 | 8 | 7 | 5 | |||
| Median viral load (log10 copies/mL) | 7.2 | 8.2 | 0.5 | 7.7 | 6.6 | < 0.01 | 7.6 | 3.1 | < 0.01 |
| Urine (n = 111) | |||||||||
| RT-qPCR (+) (n = 32) | 29 | 3 | 0.7 | 20 | 12 | 0.2 | 29 | 3 | < 0.01; 7.2 (1.6–32.9) |
| RT-qPCR (–) (n = 79) | 69 | 10 | 38 | 41 | 50 | 29 | |||
| Median viral load (log10 copies/mL) | 0 | 0 | 0.3 | 0 | 0 | 0.2 | 0 | 0 | < 0.01 |
aRT-qPCR, quantitative reverse transcription–polymerase chain reaction; SARS, severe acute respiratory syndrome; Y, yes; N, no; OR, odds ratio; CI, 95% confidence interval; NPA, nasopharyngeal aspirates.
Page created: March 29, 2011
Page updated: March 29, 2011
Page reviewed: March 29, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.